The Report Guru

According to the new market research Healthcare Integration Market   is expected to reach USD 3.73 Billion by 2021 from USD 2.30 Billion in 2016, at a CAGR of 10.2% from 2016 to 2021. In the last few years, the healthcare integration market has witnessed substantial growth across globe. This market is mainly driven by factors such as rising healthcare costs, strong government support and initiatives, the growing need to integrate healthcare systems, and efforts from healthcare providers to maximize their returns on investment. However, various interoperability issues, a fragmented end-users market, and the high cost of implementation for healthcare IT integration solutions are posing several challenges to the overall growth of the market. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=228536178 The healthcare integration market in North America and Europe is growing at a significant rate owing to the rising government incentives, presence of highly de

According to research report the Neuroscience Antibodies and Assays Market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%. The growth of this market can be attributed to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. Agreements, partnerships, and collaborations accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018. Some of the companies that adopted this strategy include Cell Signaling Technology (US), Abcam (UK), Rockland Immunochemicals (US), BioLegend (US), Tecan (Switzerland), and Merck KGaA (Germany). Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=129888612 The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. In 2017, Thermo Fisher Scientific (US), Abcam (U

According to research report the laboratory informatics market is expected to reach USD 3.16 billion by 2022 from USD 2.32 billion in 2017, at a CAGR of 6.4% during the forecast period. The market is witnessing growth due to factors such as increasing need for laboratory automation, development for integrated lab informatics solutions, growing demand in biobanks/biorepositories, academic research institutes, and CROs, and need to comply with regulatory standards. The emergence of cloud-based services via the internet has led to significant advances in the laboratory informatics market. Advances in virtualization and improved access to high-speed internet offers innovative solutions often at lower costs. With cloud-based solutions, companies are only required to pay for the software subscription instead of purchasing full licenses, which reduces the maintenance costs related to in-house deployment. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=2030

Factors such as the rising awareness about oral hygiene, growing incidence of dental diseases, and technological advancements in oral care products are expected to drive the growth of the oral care market. Increasing online purchase of oral care products is expected to create new growth opportunities for players operating in this market. The oral care market is projected to reach USD 53.3 billion by 2025 from USD 44.5 billion in 2019, at a CAGR of 3.0%. The toothpastes segment is expected to account for the largest share of the oral care market in 2019. Based on product, the oral care market is categorized into toothpastes, toothbrushes & accessories, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthesis cleaning solutions. In 2019, the toothpastes segment is expected to account for the largest share of the oral care market. The large share of this segment can primarily be attributed to the huge adoption of toothpastes for maintaining oral hyg

According to research report the digital PCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019. The market is expected to grow at a CAGR of 8.8% from 2019 to 2024. The growth of the market is primarily driven by the rising incidences of target infectious diseases and genetic disorders, increasing financial support for research, and the increasing use of biomarker profiling in disease diagnostics. Companies in the digital PCR market are focusing on novel product development (including lab-on-chip devices, miniaturized devices, and microfluidics-based instruments) to cater to the growing end-user demand for technologically advanced dPCR and qPCR products. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The qPCR reagents & consumables segment is expected to command the largest share of the qPCR products & services market. Factors such as the expanding applications of qPCR (owing to its technological

According to research report the cardiac monitoring devices market is expected to reach $30.56 billion by 2027 from $22.12 billion in 2019, at a CAGR of 4.0%. The scope of the report includes cardiac monitoring and cardiac rhythm management devices used for continuous monitoring, detection, and treatment of heart activities and abnormal heart rhythm (electric heart patterns). Factors driving the growth of this market include increasing incidence of cardiovascular diseases and technological advancements in devices. However, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the CM & CRM devices market. Read More : https://www.marketsandmarkets.com/PressReleases/cardiac-monitoring.asp Based on end user, the cardiac monitoring and cardiac rhythm management devices market is segmented into hospitals, home and ambulatory care settings, and other end users. In 2017, the hospitals segment accounted for the larg

According to research report the global dental sterilization market is projected to reach USD 1.48 billion by 2023 from USD 1.08 billion in 2018, at a CAGR of 6.6%. Factors such as the increasing number of dental facilities and the growing pool of dental care personnel, growing prevalence of dental ailments, and the increasing demand for cosmetic dentistry are expected to drive the market. The emerging markets are expected to provide a wide range of growth opportunities for players in the market. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837 In this report, the dental sterilization market is segmented based on product, end user, and region. On the basis of product, the market is further classified into instruments and consumables & accessories. The sterilization packaging accessories segment accounted for the largest share of the global dental sterilization consumables & accessories market in 2017. The large share of this segment c

According to research report the global  Preclinical Imaging Market  is estimated to grow at a CAGR of 6.2% from 2016 to 2021 to reach USD 910.4 Million by 2021. The key players in the Preclinical Molecular Imaging Market focus on various strategies such as product approvals, launches, and enhancements; geographic expansions; partnerships, agreements, and collaborations; and strategic acquisitions in order to increase their market shares in the global Preclinical Molecular Imaging Market. Product approvals, launches, and enhancements was the key strategy adopted by major industry players to achieve growth in the Preclinical Molecular Imaging Market.  Download Brochure :  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841   This strategy was majorly adopted by PerkinElmer, Inc. (U.S.), Bruker Corporation (U.S.), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), and Aspect Imaging Ltd. (Israel). Apart from product approvals, launches, and enhancements;

Market growth factors Key factors such continuous advancements in spine surgery technologies, increasing incidence of spinal disorders, technological developments in bone grafting products, increasing demand for minimally invasive surgical procedures, rising geriatric and obese population are driving the growth of this market. What experts says about the growth of this market? According to the new market research report Spinal Implants Market is expected to reach USD 17.27 billion by 2021, growing at CAGR of 5.3% during the forecast period. Download PDF Brochure :  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712 Spinal Implants and Surgical Devices Market by Technology (Fusion, Fixation, VCF, Decompression, Motion Preservation), Product (Thoracic, Lumbar, Cervical, Interbody, Kyphoplasty, Artificial Discs, MIS, Biologics, Stimulators) - Global Forecast to 2021 Motion preservation/non-fusion technology segment to grow at fastest rate during the forecast period.  On the bas

According to the new market research report  Defibrillators Market  is projected to reach USD 10,883.3 million by 2022 from USD 9,323.5 million in 2017 at a CAGR of 3.1%. Factors such as technological advancements in defibrillators, increasing burden of target diseases, growing focus on providing public-access defibrillators, and rising number of training & awareness programs on defibrillators are driving the growth of this market. Report Sample Pages:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=549   The report analyzes the global market by product, end user, and region. The implantable cardioverter defibrillators (ICDs) segment is expected to account for the largest share of the defibrillators market, by product type, in 2017 On the basis of products, the market is classified into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs product segment is bifurcated into transvenous implantable cardioverter defibrillators (T-ICDs) and s

According to the new market research report dPCR and qPCR Market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8%. The rising incidences of target diseases (such as HIV, malaria, tuberculosis, and cancer) and genetic disorders; increasing use of biomarker profiling for disease diagnosis and monitoring; and successful completion of the Human Genome Sequencing Project are a few key factors driving the growth of this market. In addition, ongoing technological advancements in PCR technologies and support for genomic research have contributed to market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204       Reagents and consumables to dominate the qPCR market in 2019 Reagents and consumables are expected to account for the largest share among qPCR product categories in 2019. The large share of this segment is due to the expanding applications of qPCR (owing to its technological benefits ove

According to the new market research report  ECMO Machine Market  is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. A number of key players are competing against each other to expand their existing customer base. Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.) are the top three players of the extracorporeal membrane oxygenation (ECMO) machine market. These players jointly accounted for a share of 65% to 70% of the total ECMO machine market in 2015.  Know more :  https://www.marketsandmarkets.com/PressReleases/extracorporeal-membrane-oxygenation-systems.asp Getinge Group is the largest player in the global market. The company offers its ECMO products under its Maquet brand. The firm develops and commercializes ECMO products and is one of the leading manufacturers of heart-lung machines, oxygenators, pumps, catheters, cannulae, and other accessories. The company’s business segments include Medical Systems, Extended

According to research report the global IVD quality control market is expected to reach USD 1.04 billion by 2022, at a CAGR of 3.5% from 2017 to 2022. The global IVD quality controls market is oligopolistic in nature with very few players accounting for a major share of the market. Bio-Rad Laboratories, Inc. (U.S.), Randox Laboratories (U.K.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in this market. A majority of the leading players in this market are based in developed countries across North America and Europe. Read more : https://www.marketsandmarkets.com/PressReleases/in-vitro-diagnostics-quality-controls.asp In 2016, Bio-Rad Laboratories held the leading position in the IVD quality controls market. This can be attributed to its highly diversified quality controls portfolio, which includes controls for immunoassay, therapeutic drug monitoring, serum chemistry, and urine chemistry; urinalysis controls; cardiac assessment quality controls; immunology/protein

According to research the research report Ambulatory EHR Market is expected to reach USD 5.20 billion by 2021 from USD 3.92 billion in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). The Ambulatory EHR market is dominated by Cerner Corporation (U.S.) and McKesson Corporation (U.S.) Read More - https://www.marketsandmarkets.com/PressReleases/ambulatory-ehr.asp Cerner Corporation (U.S.) is one of the largest players in the market. In order to remain competitive, the company primarily adopted growth strategies such as agreements, collaborations, and partnerships for enhancing its presence in the market. For instance, in 2016, The UAE Ministry of Health and Prevention (MOHAP) renewed its strategic agreement with Cerner Corporation. Similarly, in 2015, Truman Medical Centers (TMC) (U.S.) partnered with Cerner Corporation to leverage Cerner’s health care information technology (IT) solutions. Epic Corporation (U.S.) is another prominent player in the ambulatory EHR market

According to research report the Depth of Anesthesia Monitoring Market is projected to reach USD 170 million by 2024, at a CAGR of 3.2% during the forecast period. The growth of this market can largely be attributed to the rising patient pool in hospitals and the increasing number of surgeries in the US. However, depth of anesthesia monitoring devices are expensive and have considerably high installation and maintenance costs. Owing to this, their adoption is limited in small outpatient settings and clinics. Read More - https://www.marketsandmarkets.com/PressReleases/depth-anesthesia-monitoring.asp The prominent players operating in this market are Masimo Corporation (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), GE Healthcare (US), Mennen Medical Ltd. (Israel), Medtronic Public Limited Company (Ireland), and Philips Healthcare (Netherlands). These players focused on strategic partnerships, acquisitions, and the launch of new products to increase their presence

According to research the research report Ambulatory EHR Market is expected to reach USD 5.20 billion by 2021 from USD 3.92 billion in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). The Ambulatory EHR market is dominated by Cerner Corporation (U.S.) and McKesson Corporation (U.S.) Read More : https://www.marketsandmarkets.com/PressReleases/ambulatory-ehr.asp Cerner Corporation (U.S.) is one of the largest players in the market. In order to remain competitive, the company primarily adopted growth strategies such as agreements, collaborations, and partnerships for enhancing its presence in the market. For instance, in 2016, The UAE Ministry of Health and Prevention (MOHAP) renewed its strategic agreement with Cerner Corporation. Similarly, in 2015, Truman Medical Centers (TMC) (U.S.) partnered with Cerner Corporation to leverage Cerner’s health care information technology (IT) solutions. Epic Corporation (U.S.) is another prominent player in the ambulatory EHR market. T

According to research report the global  competent cells market  is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%.The growth of this market is attributed to factors such as advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins. Product launches, acquisitions, and partnerships were some of the major strategies followed by key players in the competent cells market. These strategies were adopted by—Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), New England Biolabs (U.S.), GenScript Biotech Corporation (China), and Agilent Technologies, Inc. (U.S.). Speak to Analyst :  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=265815900   Thermo Fisher Scientific, Inc. is one of the key players in the competent cells market. The company focuses on product launches, acquisitions, and agreements to enhance